Developing Medical Imaging Drug and Biological Products Part 3: Design, Analysis, and Interpretation of Clinical Studies
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 22, 2004
April 28, 2020
560bad6d-d575-4a09-84e7-a396f541a476
Related Documents
Developing Medical Imaging Drug and Biological Products Part 1: Conducting Safety Assessments
Guidance DocumentJune 22, 2004Center for Drug Evaluation and Research
Clinical Studies Section of Labeling for Human Prescription Drug and Biological Products — Content and Format: Guidance for Industry
Guidance DocumentJanuary 24, 2006Center for Drug Evaluation and Research
Developing Medical Imaging Drug and Biological Products Part 2: Clinical Indications
Guidance DocumentJune 22, 2004Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox